ACADIA Pharmaceuticals to Announce First Quarter 2019 Financial Results on May 1, 2019

SAN DIEGO–(BUSINESS WIRE)–ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, today announced that it will report its financial results for the first quarter ended March 31, 2019 on Wednesday, May 1, 2019, after the U.S. financial markets close. ACADIA?s management will host a conference call and webcast on Wednesday, May 1, 2019, a